Teleflex closes deal with BIOTRONIK

6 days ago 1
Set of flying one hundred dollars bills. Isolated on white

choness/iStock via Getty Images

  • Teleflex Incorporated (NYSE:TFX) said that it completed the previously announced acquisition of the Vascular Intervention business of BIOTRONIK SE.
  • Since the Vascular Intervention acquisition was completed earlier than anticipated, the company now projects that the acquired products will bring in €177M, in revenue in the second half of 2025.

Recommended For You

More Trending News

Read Entire Article